Edit |   |
---|---|
Antigenic Specificity | CD20 receptors, Human (Veltuzumab biosimilar) |
Clone | Veltuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | n/a |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD20R Recombinant Antibody. Veltuzumab is a monoclonal antibody (targeted at CD20) which is being investigated for the treatment of non-Hodgkin's lymphoma. As of December 2011, it is undergoing Phase I/II clinical trials. When used with milatuzumab it showed activity. |
Immunogen | n/a |
Other Names | Anti-CD20R Recombinant Antibody, Research Grade Veltuzumab, Anti-Human CD20R Recombinant Antibody, hA20/IMMU-106, Antibody Drug Analogues, Monoclonal Antibody, YR1608, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 728917-18-8 |
Catalog # | YR1608 |
Price | please inquire |
Order / More Info | CD20 receptors, Human (Veltuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |